Keywords: barr, bijuva, gets, non-approvable, letter, fda, generics

Barr's Bijuva gets non-approvable letter from US FDA

Article | 28 April 2005

Print This

US generics firm Barr Pharmaceuticals says that the US Food and Drug Administration has issued a non-approvable letter to Duramed ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in